pre-seed
Stage
About
Cornea Sense develops a medical diagnostic device that measures ocular surface hydration to help eye doctors diagnose and monitor ocular and metabolic diseases such as dry eye and diabetes. The company has a prototype validated on phantom models and is transitioning to first human-eye measurements and clinical validation.
Explore Cornea Sense's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.